Benefits and Risks of Antiretroviral Therapy for Perinatal H
Antiretroviral regimens used for the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) have evolved from the first successful trial that used zidovudine single-drug prophylaxis in 1994 to current triple-drug regimens. Although there are clear benefits of combination antiretroviral therapy (ART) for the mother and infant, these do not come without risks; some studies have shown higher rates of adverse pregnancy outcomes with maternal ART than with regimens containing fewer antiretroviral agents...

http://www.nejm.org/doi/full/10.1056/NEJMoa1511691?query=featured_obstetrics-gynecology#t=articleTop
Like
Comment
Share